Patel looks for product collaboration with other companies
California-headquartered APNAR Pharma LP, with manufacturing centres in Gavasad, Gujarat, and East Windsor, New Jersey, has acquired Aurex Laboratories for an undisclosed amount.
This acquisition enhances APNAR’s capabilities, scale, and global footprint and broadens APNAR’s pipeline.
Aurex is based in East Windsor.
“As part of our well-defined strategy and commitment of having manufacturing in the United States of America, we are excited to acquire Aurex. This milestone will position APNAR as a company with global footprint in the US and India,” APNAR President Dharmesh Patel said on 3 Feb 2022.
APNAR COO Sanjay Bhargav added, “In addition to adding state-of-the-art facility to APNAR’s capabilities in the US, we are pleased to welcome to APNAR an amazing team that is experienced, highly capable, and dedicated including scientists, manufacturing, regulatory, and project management personnel.”
“In addition to developing and manufacturing APNAR’s own products, we are looking forward to working in a collaborative manner with other companies for contract and co-development and contract manufacturing,” added Patel.
“We look forward to manufacturing APNAR’s 5 ANDAs and other drugs in the US to ensure supply chain security and excellence,” added Bhargav.
Nailesh Bhatt acted as a strategic advisor to both Aurex Laboratories and APNAR Pharma. fiinews.com
